USC.edu
Are You a Patient?

Kyle M. Hurth, MD, PhD

Associate Professor of Clinical Pathology

Program Director, Neuropathology Fellowship Program

Immunohistochemistry Laboratory Director

Image of Kyle M. Hurth, MD, PhD
Is this your profile? Click to edit
Phone +1 323 442 8592
Email [email protected]
CTSI Profile

Publications

  • Multi-Center, Multi-National Outcomes Following Endoscopic Endonasal Resection of Nonfunctional Pituitary Adenomas. J Neurol Surg B Skull Base. 2026 Apr; 87(2):151-156.. View in PubMed
  • Association between meningioma consistency and surgical outcomes. J Neurosurg. 2025 May 01; 142(5):1331-1337.. View in PubMed
  • Successful Multimodal Management of an Aggressive Functional Gonadotropic Pituitary Macroadenoma. AACE Clin Case Rep. 2025 Jan-Feb; 11(1):14-17.. View in PubMed
  • Intracranial meningioma: A review of recent and emerging data on the utility of preoperative imaging for management. J Neuroimaging. 2024 Sep-Oct; 34(5):527-547.. View in PubMed
  • Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy. Ann Clin Transl Neurol. 2024 03; 11(3):629-640.. View in PubMed
  • Clinical Implications of Pituitary Adenomas Exhibiting Dual Transcription Factor Staining: A Case Series of 27 Patients. World Neurosurg. 2024 02; 182:e62-e66.. View in PubMed
  • ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS Metastasis. Clin Cancer Res. 2023 11 01; 29(21):4492-4503.. View in PubMed
  • A repository of grade 1 and 2 meningioma MRIs in a public dataset for radiomics reproducibility tests. Med Phys. 2024 Mar; 51(3):2334-2344.. View in PubMed
  • Breast-to-brain metastasis is exacerbated with chemotherapy through blood-cerebrospinal fluid barrier and induces Alzheimer’s-like pathology. J Neurosci Res. 2023 12; 101(12):1900-1913.. View in PubMed
  • Neurotropism of SARS-CoV-2: A Pathological Examination of Neurosurgical Specimens. Neurosurgery. 2024 02 01; 94(2):379-388.. View in PubMed

Similar People